Novel anti-TNFRSF21 antibodies and methods of use

Provided are novel anti-TNFRSF21 antibodies and antibody drug conjugates, and methods of using such anti-TNFRSF21 antibodies and antibody drug conjugates to treat cancer.

Saved in:
Bibliographic Details
Main Authors Boontanrart, Mandy, Bishop, Evan, Aujay, Monette, Bankovich, Alexander John, Saunders, Laura, Liu, David, Rokkam, Deepti, Huang, Zhao
Format Patent
LanguageEnglish
Published 15.11.2018
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Provided are novel anti-TNFRSF21 antibodies and antibody drug conjugates, and methods of using such anti-TNFRSF21 antibodies and antibody drug conjugates to treat cancer.
Bibliography:Application Number: AU20170261369